Jefferies Financial Group Inc. Pfizer Inc Call Options Transaction History

Jefferies Financial Group Inc.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $8.31 Million - $9.42 Million	-300,000 Reduced 75.74%	96,100 $2.78 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $5.96 Million - $6.98 Million	235,900 Added 147.25%	396,100 $11.1 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $1.95 Million - $2.24 Million	-75,400 Reduced 32.0%	160,200 $4.45 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $6.16 Million - $8 Million	235,600 New	235,600 $6.78 Million
Q4 2022 Sep 21, 2023	BUY	$41.75 - $54.5 $4.59 Million - $6 Million	110,000 New	110,000 $5.64 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $4.59 Million - $6 Million	110,000 New	110,000 $5.64 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.